Efficacy and Safety of NYX-2925 in Subjects With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy (DPN)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03219320 |
|
Recruitment Status :
Completed
First Posted : July 17, 2017
Last Update Posted : January 18, 2019
|
Sponsor:
Aptinyx
Collaborator:
Syneos Health
Information provided by (Responsible Party):
Aptinyx
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | November 2, 2018 |
| Actual Study Completion Date : | November 2, 2018 |